• Thu, November 11, 2021

by: WOPRAI

Christopher Carril Maintained (WEN) at Hold with Decreased Target to $24 on, Nov 11th, 2021

by: WOPRAI

Scott Gruber Maintained (WHD) at Strong Buy with Increased Target to $50 on, Nov 11th, 2021

by: WOPRAI

Spiro Dounis Maintained (WMB) at Buy with Increased Target to $33 on, Nov 11th, 2021

by: WOPRAI

Nicholas Bacchus Maintained (VRM) at Buy on, Nov 11th, 2021

by: WOPRAI

James Faucette Maintained (TTEC) at Hold with Decreased Target to $100 on, Nov 11th, 2021

by: WOPRAI

Marc Goodman Maintained (XENE) at Buy with Increased Target to $40 on, Nov 11th, 2021

by: WOPRAI

Paul Knight Maintained (XGN) at Buy with Decreased Target to $30 on, Nov 11th, 2021

by: WOPRAI

Matthew Hedberg Upgraded (XMTR) to Buy and Decreased Target to $53 on, Nov 11th, 2021

by: WOPRAI

Aaron Kessler Maintained (UP) at Buy with Decreased Target to $90 on, Nov 11th, 2021

by: WOPRAI

Stephen Ju Maintained (UP) at Buy with Decreased Target to $110 on, Nov 11th, 2021

by: WOPRAI

Jeffrey Meuler Upgraded (SPIR) to Buy and Held Target at $80 on, Nov 11th, 2021

by: WOPRAI

Jason Celino Maintained (STER) at Buy with Increased Target to $31 on, Nov 11th, 2021

by: WOPRAI

Casey Alexander Downgraded (SLRC) to Hold and Held Target at $20 on, Nov 11th, 2021

by: WOPRAI

Mayank Tandon Maintained (COMP) at Strong Buy with Decreased Target to $18 on, Nov 11th, 2021

by: WOPRAI

Ross Sandler Maintained (COMP) at Hold with Decreased Target to $18 on, Nov 11th, 2021

by: WOPRAI

James Goss Upgraded (CCO) to Buy and Held Target at $5 on, Nov 11th, 2021

by: WOPRAI

Daniel Perlin Maintained (TASK) at Buy with Increased Target to $69 on, Nov 11th, 2021

by: WOPRAI

Kenneth Zener Maintained (SWIM) at Buy with Increased Target to $27 on, Nov 11th, 2021

by: WOPRAI

Matthew Bouley Maintained (SWIM) at Buy with Increased Target to $26 on, Nov 11th, 2021

by: WOPRAI

Rafe Jadrosich Upgraded (SWIM) to Strong Buy and Increased Target to $27 on, Nov 11th, 2021

by: WOPRAI

Stephen Laws Maintained (STWD) at Buy with Increased Target to $32 on, Nov 11th, 2021

by: WOPRAI

Joseph Schwartz Maintained (SYBX) at Buy with Decreased Target to $165 on, Nov 11th, 2021

by: WOPRAI

Subash Chandra Initiated (TMC) at Hold on, Nov 11th, 2021

by: WOPRAI

Chuck Grom Upgraded (TJX) to Strong Buy and Increased Target to $84 on, Nov 11th, 2021

by: WOPRAI

Stephen Gengaro Downgraded (TPIC) to Hold and Decreased Target to $27 on, Nov 11th, 2021

by: WOPRAI

Randal Konik Maintained (TPR) at Hold with Increased Target to $50 on, Nov 11th, 2021

by: WOPRAI

Silvan Tuerkcan Maintained (TSHA) at Buy with Decreased Target to $38 on, Nov 11th, 2021

by: WOPRAI

Chuck Grom Upgraded (TSCO) to Strong Buy and Increased Target to $240 on, Nov 11th, 2021

by: WOPRAI

Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $8 on, Nov 11th, 2021

by: WOPRAI

Robert Dodd Maintained (BBDC) at Strong Buy with Increased Target to $13 on, Nov 11th, 2021

by: WOPRAI

Colin Sebastian Maintained (BABA) at Buy and Held Target at $260 on, Nov 11th, 2021

by: WOPRAI

Elemer Piros Initiated (ATAI) at Strong Buy and Held Target at $32 on, Nov 11th, 2021

by: WOPRAI

Heiko Ihle Maintained (ASM) at Strong Buy with Decreased Target to $1.25 on, Nov 11th, 2021

by: WOPRAI

Michael Sison Maintained (ASH) at Buy with Increased Target to $115 on, Nov 11th, 2021

by: WOPRAI

Chris Shaw Downgraded (ASH) to Hold on, Nov 11th, 2021

by: WOPRAI

Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $179 on, Nov 11th, 2021

by: WOPRAI

Vijay Rakesh Maintained (AVGO) at Strong Buy with Increased Target to $60 on, Nov 11th, 2021

by: WOPRAI

Alexia Howard Downgraded (BYND) to Hold and Held Target at $100 on, Nov 11th, 2021

by: WOPRAI

Robert Moskow Maintained (BYND) at Sell with Decreased Target to $60 on, Nov 11th, 2021

by: WOPRAI

Michael Lavery Maintained (BYND) at Sell with Decreased Target to $72 on, Nov 11th, 2021

by: WOPRAI

Joe Quatrochi Maintained (AMAT) at Buy with Increased Target to $175 on, Nov 11th, 2021

by: WOPRAI

Tal Liani Downgraded (ALLT) to Hold and Decreased Target to $14 on, Nov 11th, 2021

by: WOPRAI

Andrew Charles Maintained (BROS) at Buy with Increased Target to $70 on, Nov 11th, 2021

by: WOPRAI

Brad Erickson Maintained (BMBL) at Buy with Decreased Target to $55 on, Nov 11th, 2021

by: WOPRAI

Arvind Ramnani Maintained (BLND) at Buy with Decreased Target to $19 on, Nov 11th, 2021

by: WOPRAI

Chuck Grom Upgraded (BJ) to Strong Buy and Held Target at $70 on, Nov 11th, 2021

by: WOPRAI

Trevor Williams Initiated (BKKT) at Hold and Held Target at $700 on, Nov 11th, 2021

by: WOPRAI

Andrew Fein Maintained (ZNTL) at Strong Buy with Increased Target to $120 on, Nov 11th, 2021

Tiago Fauth Maintained (ASND) at Buy with Decreased Target to $179 on, Nov 11th, 2021

Tiago Fauth of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $185 to $179 on, Nov 11th, 2021.

Tiago has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Increased Target to $169 on, Wednesday, October 20th, 2021


These are the ratings of the 2 analyists that currently disagree with Tiago

  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $204 on, Thursday, August 26th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $182 on, Thursday, August 26th, 2021

Like: 👍